☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
parkinson’s disease
Kyowa Kirin's Nourianz (istradefylline) Receives FDA's Approval as an Adjunctive Therapy in Patients with Parkinson's Disease
August 28, 2019
Kyowa Kirin Signs an Exclusive Commercialization Agreement with Hisamitsu for its HP-3000
February 6, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
